Adding immune checkpoint inhibitors to percutaneous hepatic perfusion may improve survival outcomes in metastatic uveal melanoma.
HealthDay News — For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, ...
Metastatic uveal melanoma commonly spreads to the liver, and percutaneous hepatic perfusion can help control tumors within ...
A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results